{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:05:33Z","timestamp":1771326333842,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,17]]},"DOI":"10.7759\/cureus.103758","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T10:05:56Z","timestamp":1771322756000},"source":"Crossref","is-referenced-by-count":0,"title":["Lipodystrophies in Clinical Practice: A Case Series From a Local Health Unit in Portugal"],"prefix":"10.7759","author":[{"given":"Renata","family":"Barbosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana T","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Borges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ermelinda S","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge Diogo","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Rita","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Guia pra\u0301ctica para o diagno\u0301stico e tratamento das lipodistrofias raras. AELIP (Asociaci\u00f3n Internacional","author":"Ara\u00fajo\u2011Vilar D","year":"2020","unstructured":"Ara\u00fajo\u2011Vilar D, S\u00e1nchez\u2011Iglesias S, Guill\u00edn\u2011Amarelle C, Fern\u00e1ndez\u2011Pombo A. Guia pra\u0301ctica para o diagno\u0301stico e tratamento das lipodistrofias raras.  AELIP (Asociaci\u00f3n Internacional de Familiares y Afectados de Lipodistrofia), 2020. https:\/\/aelip.es\/wp-content\/uploads\/2024\/09\/GUIA-DEFINITIVA-PORTUGUES-PDF-2.pdf."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2466","article-title":"The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline","volume":"101","author":"Brown RJ","year":"2016","unstructured":"Brown RJ, Araujo-Vilar D, Cheung PT, et al.. The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline. J Clin Endocrinol Metab. 2016, 101:4500-11. 10.1210\/jc.2016-2466","journal-title":"J Clin Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2021.104071","article-title":"Familial partial lipodystrophy syndromes","volume":"50","author":"Fern\u00e1ndez-Pombo A","year":"2021","unstructured":"Fern\u00e1ndez-Pombo A, S\u00e1nchez-Iglesias S, Cobelo-G\u00f3mez S, Hermida-Ameijeiras \u00c1, Ara\u00fajo-Vilar D. Familial partial lipodystrophy syndromes. Presse Med. 2021, 50:104071. 10.1016\/j.lpm.2021.104071","journal-title":"Presse Med"},{"key":"ref4","unstructured":"Congenital generalized lipodystrophy. (2019). Accessed. January 2, 2026: https:\/\/medlineplus.gov\/genetics\/condition\/congenital-generalized-lipodystrophy\/."},{"key":"ref5","unstructured":"Orphanet. Familial partial lipodystrophy. (2020). Accessed: 2 Jan 2026: https:\/\/www.orpha.net\/en\/disease\/detail\/98306."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2337\/db19-0447","article-title":"Clinical and molecular prevalence of lipodystrophy in an unascertained large clinical care cohort","volume":"69","author":"Gonzaga-Jauregui C","year":"2020","unstructured":"Gonzaga-Jauregui C, Ge W, Staples J, et al.. Clinical and molecular prevalence of lipodystrophy in an unascertained large clinical care cohort. Diabetes. 2020, 69:249-58. 10.2337\/db19-0447","journal-title":"Diabetes"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2018.11.004","article-title":"Lipodystrophies, dyslipidaemias and atherosclerotic cardiovascular disease","volume":"51","author":"Hussain I","year":"2019","unstructured":"Hussain I, Patni N, Garg A. Lipodystrophies, dyslipidaemias and atherosclerotic cardiovascular disease. Pathology. 2019, 51:202-12. 10.1016\/j.pathol.2018.11.004","journal-title":"Pathology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-018-0887-z","article-title":"Diagnosis and treatment of lipodystrophy: a step-by-step approach","volume":"42","author":"Ara\u00fajo-Vilar D","year":"2019","unstructured":"Ara\u00fajo-Vilar D, Santini F. Diagnosis and treatment of lipodystrophy: a step-by-step approach. J Endocrinol Invest. 2019, 42:61-73. 10.1007\/s40618-018-0887-z","journal-title":"J Endocrinol Invest"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02142","article-title":"Autoantibodies against perilipin 1 as a cause of acquired generalized lipodystrophy","volume":"9","author":"Corvillo F","year":"2018","unstructured":"Corvillo F, Aparicio V, L\u00f3pez-Lera A, Garrido S, Ara\u00fajo-Vilar D, de Miguel MP, L\u00f3pez-Trascasa M. Autoantibodies against perilipin 1 as a cause of acquired generalized lipodystrophy. Front Immunol. 2018, 9:2142. 10.3389\/fimmu.2018.02142","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-018-1099-9","article-title":"Phenotypic and genetic characteristics of lipodystrophy: pathophysiology, metabolic abnormalities, and comorbidities","volume":"18","author":"Akinci B","year":"2018","unstructured":"Akinci B, Meral R, Oral EA. Phenotypic and genetic characteristics of lipodystrophy: pathophysiology, metabolic abnormalities, and comorbidities. Curr Diab Rep. 2018, 18:143. 10.1007\/s11892-018-1099-9","journal-title":"Curr Diab Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvaf214","article-title":"Epidemiological and clinical data from the European Lipodystrophy Registry","volume":"193","author":"Ceccarini G","year":"2025","unstructured":"Ceccarini G, Vatier C, Akinci B, et al.. Epidemiological and clinical data from the European Lipodystrophy Registry. Eur J Endocrinol. 2025, 193:685-703. 10.1093\/ejendo\/lvaf214","journal-title":"Eur J Endocrinol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-025-01733-5","article-title":"Brazilian expert consensus on the diagnosis, classification, screening for complications and treatment of familial partial lipodystrophy","volume":"17","author":"Valerio CM","year":"2025","unstructured":"Valerio CM, Viola LF, Guidorizzi NR, et al.. Brazilian expert consensus on the diagnosis, classification, screening for complications and treatment of familial partial lipodystrophy. Diabetol Metab Syndr. 2025, 17:186. 10.1186\/s13098-025-01733-5","journal-title":"Diabetol Metab Syndr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S206053","article-title":"Familial partial lipodystrophy (FPLD): recent insights","volume":"13","author":"Bagias C","year":"2020","unstructured":"Bagias C, Xiarchou A, Bargiota A, Tigas S. Familial partial lipodystrophy (FPLD): recent insights. Diabetes Metab Syndr Obes. 2020, 13:1531-44. 10.2147\/DMSO.S206053","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1250203","article-title":"Natural history and comorbidities of generalised and partial lipodystrophy syndromes in Spain","volume":"14","author":"Fern\u00e1ndez-Pombo A","year":"2023","unstructured":"Fern\u00e1ndez-Pombo A, S\u00e1nchez-Iglesias S, Castro-Pais AI, et al.. Natural history and comorbidities of generalised and partial lipodystrophy syndromes in Spain. Front Endocrinol (Lausanne). 2023, 14:1250203. 10.3389\/fendo.2023.1250203","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2025.101730","article-title":"Lipodystrophy and severe insulin resistance syndrome: epidemiological data from a French national rare diseases registry","volume":"86","author":"Vantyghem MC","year":"2025","unstructured":"Vantyghem MC, Nob\u00e9court E, Vatier C, et al.. Lipodystrophy and severe insulin resistance syndrome: epidemiological data from a French national rare diseases registry. Ann Endocrinol (Paris). 2025, 86:101730. 10.1016\/j.ando.2025.101730","journal-title":"Ann Endocrinol (Paris)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512045","article-title":"Familial partial lipodystrophy: clinical features, genetics and treatment in a Greek referral center","volume":"24","author":"Kountouri A","year":"2023","unstructured":"Kountouri A, Korakas E, Maratou E, et al.. Familial partial lipodystrophy: clinical features, genetics and treatment in a Greek referral center. Int J Mol Sci. 2023, 24:12045. 10.3390\/ijms241512045","journal-title":"Int J Mol Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-022-01485-w","article-title":"Lipodystrophy for the diabetologist-what to look for","volume":"22","author":"Patni N","year":"2022","unstructured":"Patni N, Garg A. Lipodystrophy for the diabetologist-what to look for. Curr Diab Rep. 2022, 22:461-70. 10.1007\/s11892-022-01485-w","journal-title":"Curr Diab Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1210\/en.2003-0870","article-title":"Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome","volume":"144","author":"Unger RH","year":"2003","unstructured":"Unger RH. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology. 2003, 144:5159-65. 10.1210\/en.2003-0870","journal-title":"Endocrinology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.124.320774","article-title":"Hypertriglyceridemia results from an impaired catabolism of triglyceride-rich lipoproteins in PLIN1-related lipodystrophy","volume":"44","author":"Verg\u00e8s B","year":"2024","unstructured":"Verg\u00e8s B, Vantyghem MC, Reznik Y, Duvillard L, Rouland A, Capel E, Vigouroux C. Hypertriglyceridemia results from an impaired catabolism of triglyceride-rich lipoproteins in PLIN1-related lipodystrophy. Arterioscler Thromb Vasc Biol. 2024, 44:1873-83. 10.1161\/ATVBAHA.124.320774","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.20150.1","article-title":"Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function","volume":"8","author":"Bruder-Nascimento T","year":"2019","unstructured":"Bruder-Nascimento T, Kress TC, Belin de Chantemele EJ. Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function. F1000Res. 2019, 8:1000. 10.12688\/f1000research.20150.1","journal-title":"F1000Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2337\/db21-1086","article-title":"Characterization and clinical association of autoantibodies against perilipin 1 in patients with acquired generalized lipodystrophy","volume":"72","author":"Corvillo F","year":"2023","unstructured":"Corvillo F, Abel BS, L\u00f3pez-Lera A, et al.. Characterization and clinical association of autoantibodies against perilipin 1 in patients with acquired generalized lipodystrophy. Diabetes. 2023, 72:71-84. 10.2337\/db21-1086","journal-title":"Diabetes"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/pai.70026","article-title":"Perilipin-1 autoantibodies are a robust marker of acquired lipodystrophy and may precede clinical detection","volume":"36","author":"Triaille C","year":"2025","unstructured":"Triaille C, Corvillo F, Mertens A, et al.. Perilipin-1 autoantibodies are a robust marker of acquired lipodystrophy and may precede clinical detection. Pediatr Allergy Immunol. 2025, 36:e70026. 10.1111\/pai.70026","journal-title":"Pediatr Allergy Immunol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2337\/db21-1172","article-title":"Autoantibodies to Perilipin-1 define a subset of acquired generalized lipodystrophy","volume":"72","author":"Mandel-Brehm C","year":"2023","unstructured":"Mandel-Brehm C, Vazquez SE, Liverman C, et al.. Autoantibodies to Perilipin-1 define a subset of acquired generalized lipodystrophy. Diabetes. 2023, 72:59-70. 10.2337\/db21-1172","journal-title":"Diabetes"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-1002-x","article-title":"Type 1 familial partial lipodystrophy: understanding the K\u00f6bberling syndrome","volume":"54","author":"Guill\u00edn-Amarelle C","year":"2016","unstructured":"Guill\u00edn-Amarelle C, S\u00e1nchez-Iglesias S, Castro-Pais A, et al.. Type 1 familial partial lipodystrophy: understanding the K\u00f6bberling syndrome. Endocrine. 2016, 54:411-21. 10.1007\/s12020-016-1002-x","journal-title":"Endocrine"},{"key":"ref25","unstructured":"MYALEPT (metreleptin) injection, for subcutaneous use [prescribing information]. (2022). Accessed. 2025: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/125390s024lbl.pdf."},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1896","article-title":"Insulin resistance is a sufficient basis for hyperandrogenism in lipodystrophic women with polycystic ovarian syndrome","volume":"97","author":"Lungu AO","year":"2012","unstructured":"Lungu AO, Zadeh ES, Goodling A, Cochran E, Gorden P. Insulin resistance is a sufficient basis for hyperandrogenism in lipodystrophic women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2012, 97:563-7. 10.1210\/jc.2011-1896","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/459348-lipodystrophies-in-clinical-practice-a-case-series-from-a-local-health-unit-in-portugal","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T10:05:58Z","timestamp":1771322758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/459348-lipodystrophies-in-clinical-practice-a-case-series-from-a-local-health-unit-in-portugal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.103758","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,17]]}}}